301
Views
6
CrossRef citations to date
0
Altmetric
Commentary

Could FEV1 decline have a role in daily clinical practice for asthma monitoring?

Pages 1371-1381 | Accepted 27 Jun 2013, Published online: 23 Aug 2013

References

  • Connolly CK, Prescott RJ. The Darlington and Northallerton long term asthma study: pulmonary function. BMC Pulmonary Medicine 2005;5:2
  • Lange P, Parner J, Vesto J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-200
  • James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005;171:109-14
  • KupczyK M, Kupryś I, Górski P, et al. Long-term deterioration of lung function in asthmatic outpatients. Respiration 2004;71:233-40
  • James AL, Wenzel S. Clinical relevance of airway remodeling in airway diseases. Eur Respir J 2007;30:134-55
  • Global Strategy for Asthma Management and Prevention (GINA) 2011. Available at: www.ginasthma.org [Last accessed date 10 June 2012]
  • Lieberman P, Yates SW, Welk K. Pulmonary remodeling in asthma. J Investig Allergol Clin Immunol 2001;11:220-34
  • Bergeron C, Tulic MK, Hamid Q. Airway remodeling in asthma: from benchside to clinical practice. Can Respir J 2010;17:e85-93
  • Grainge CL, Lau LC, Ward JA, et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011;364:2006-15
  • Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int 2008;57:1-10
  • Lambrecht BN, Hammad H. The airway epithelium. Nat Med 2012;18:684-92
  • Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 2011;128:451-62
  • Covar RA, Spahn JD, Murphy JR, et al. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 2004;170:234-41
  • Rasmussen F, Taylor DR, Flannery EM, et al. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002;165:1480-8
  • Kelly MM, O’Connor TM, Leigh R, et al. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol 2010;125:349-56
  • Hoshino M, Ohtawa J. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma. Respirology 2012;17:639-46
  • Hoshino M, Ohtawa J. Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma. Respiration 2012;83:520-8
  • Riccio AM, Dal Negro RW, Micheletto C, et al. Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients. Int J Immunopathol Pharmacol 2012;25:475-84
  • Busse WW, Pedersen S, Pauwels RA, et al. The inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2008;121:1167-74
  • Dompeling E, van Schayck CP, Molema J, et al. Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J 1992;5:945-52
  • Lange P, Scharling H, Ulrik CS, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006;61:100-4
  • Dompeling E, van Schayck CP, van Grunsen PM, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993;118:770-8
  • O’Byrne PM, Lamm CJ, Busse WW, et al; START Investigators Group. The effects of inhaled budesonide on lung function in smokers and non-smokers with mild persistent asthma. Chest 2009;136:1514-20
  • O’Byrne PM, Pedersen S, Busse WW, et al; START Investigators Group. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 2006;129:1478-85
  • Weiss ST, O’Connor GT, De Molles D, et al. Indoor allergens and longitudinal FEV1 decline in older adults: the Normative Aging Study. J Allergy Clin Immunol 1998;101:720-5
  • Anees W, Moore VC, Burge PS. FEV1 decline in occupational asthma. Thorax 2006;61:751-5
  • Di Giampaolo L, Cavallucci E, Braga M, et al. The persistence of allergen exposure favors pulmonary function decline in workers with allergic occupational asthma. Int Arch Occup Environ Health 2012;85:181-8
  • Di Giampaolo L, Quecchia C, Schiavone C, et al. Environmental pollution and asthma. Int J Immunopathol Pharmacol 2011;24:31-8S
  • D’Amato G, Baena-Cagnani CE, Cecchi L, et al. Climate change, air pollution and extreme events leading to increasing prevalence of allergic respiratory disease. Multidisciplinary Respiratory Medicine 2013;8:12
  • O’Byrne PM, Pedersen S, Lamm CJ, et al. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009;179:19-24
  • Bai TR, Vonk JM, Postma DS, et al. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 2007;30:452-6
  • Chakir J, Laviolette M, Boutet M, et al. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996;75:735-44
  • Milanese M, Crimi E, Scordamaglia A, et al. On the functional consequences of bronchial basement membrane thickening. J Appl Physiol 2001;91:1035-40
  • Crimi E, Milanese M, Oddera S, et al. Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol 2001;91:1029-34
  • Santamaria F, Montella S, Greco L, et al. Obesity duration is associated to pulmonary function impairment in obese subjects. Obesity (Silver Spring) 2011;19:1623-8
  • Marcon A, Corsico A, Cazzoletti L, et al; Therapy and Health Economics Group of the European Community Respiratory Health Survey. Body mass index, weight gain, and other determinants of lung function decline in adult asthma. J Allergy Clin Immunol 2009;123:1069-74
  • Beuther DA, Weiss ST, Sutherland ER. Obesity and Asthma. Am J Respir Crit Care Med 2006;174:112-19
  • Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol 2010;108:735-43
  • Wood LG, Garg ML, Gibson PG. A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J Allergy Clin Immunol 2011;127:1133-40
  • Nadeem A, Masood A, Siddiqui N. Oxidant-antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options. Ther Adv Respir Dis 2008;2:215-35
  • Nadeem A, Chhabra SK, Masood A, Raj HG. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 2003;111:72-8
  • Wood LG, Garg ML, Smart JM, et al. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr 2012;96:534-43
  • Barros R, Moreira A, Fonseca J, et al. Adherence to the Mediterranean diet and fresh fruit intake are associated with improved asthma control. Allergy 2008;63:917-23
  • Chatzi L, Apostolaki G, Bibakis I, et al. Protective effect of fruits, vegetables and the Mediterranean diet on asthma and allergies among children in Crete. Thorax 2007;62:677-83
  • Nagel G, Weinmayr G, Kleiner A, et al; ISAAC Phase Two Study Group. Effect of diet on asthma and allergic sensitization in the International Study on Allergies and Asthma in Childhood (ISAAC) phase two. Thorax 2010;65:516-22
  • Paul G, Brehm JM, Alcorn JF, et al. Vitamin D and asthma. Am J Respir Crit Care Med 2012;185:124-32
  • Li F, Peng M, Jiang L, et al. Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma. Respiration 2011;81:469-75
  • Sutherland ER, Goleva E, Jackson LP, et al. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med 2010;181:699-704
  • Wu AC, Tantisira K, Li L, et al; Childhood Asthma Management Program Research Group. Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am J Respir Crit Care Med 2012;186:508-13
  • Gupta A, Sjoukes A, Richards D, et al. Relationship between serum vitamin D, disease severity and airway remodeling in children with asthma. Am J Respir Crit Care Med 2011;184:1342-9
  • Vieira RP, Claudino RC, Duarte AC, et al. Aerobic exercise decreases chronic allergic lung inflammation and airway remodeling in mice. Am J Respir Crit Care Med 2007;176:871-7
  • Silva RA, Vieira RP, Duarte AC, et al. Aerobic training reverses airway inflammation and remodeling in an asthma murine model. Eur Respir J 2010;35:994-1002
  • Mendes FA, Almeida FM, Cukier A, et al. Effects of aerobic training on airway inflammation in asthmatic patients. Med Sci Sports Exerc 2011;43:197-203
  • De Jong PA, Müller NL, Paré PD, et al. Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J 2005;26:140-52
  • Bergeron C, Tulic MK, Hamid Q. Tools used to measure airway remodeling in research. Eur Respir J 2007;29:596-604
  • Kosciuch J, Krenke R, Gorska K, et al. Comparison of airway wall remodeling in asthma and COPD: biopsy findings. Respir Care 2012;57:557-64
  • Kohansal R, Martinez-Camblor P, Agustí A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009;180:3-10
  • Masuko H, Sakamoto T, Kaneko Y, et al. Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes smokers. Int J COPD 2011;6:181-9
  • Kalhan R, Arynchyn A, Colangelo LA, et al. Lung function in young adults predicts airflow obstruction 20 years later. Am J Med 2010;123:468.e1-7
  • Guerra S, Sherrill DL, Kurzius-Spencer M, et al. The course of persistent airflow limitation in subjects with and without asthma. Respir Med 2008;102:1473-82
  • Guerra S, Martinez FD. Epidemiology of the origins of airflow limitation in asthma. Proc Am Thorac Soc 2009;6:707-11
  • Levy ML, Quanjer PH, Booker R, et al; General Practice Airways Group. Diagnostic spirometry in primary care. Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. A General Practice Airways Group (GPIAG) document, in association with Association for Respiratory Technology and Physiology (ARTP) and Education for Health. Prim Care Respir J 2009;18:130-47
  • Levy ML, Quanjer PH, Booker R, et al. Standards for diagnostic spirometry within session repeatability in primary care. Prim Care Respir J 2012;21:252-3
  • Sposato B, Scalese M, Pammolli A, et al. Season can influence the results of the methacholine challenge test. Ann Thorac Med 2012;7:61-8
  • Sposato B, Scalese M, Pammolli A et al. Influence of outdoor temperature and humidity on the methacholine challenge test. Aerobiologia 2012;29:187-200
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38
  • Shadick NA, Sparrow D, O’Connor GT, et al. Relationship of serum IgE concentration to level and rate of decline of pulmonary function: the Normative Aging Study. Thorax 1996;51:787-92
  • Contoli M, Baraldo S, Marku B, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol 2010;125:830-7
  • Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994;150:629-34
  • Burrows B, Lebowitz MD, Barbee RA, et al. Findings prior to diagnoses of asthma among the elderly in a longitudinal study of the general population. J Allergy Clin Immunol 1991;88:870-77
  • Cibella F, Cuttitta G, Bellia V, et al. Lung function decline in bronchial asthma. Chest 2002;122:1944-8
  • Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996;312:1195-9
  • Kendrick AH, Higgs CM, Whitfield MJ, et al. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ 1993;307:422-4
  • Alvarez-Gutiérrez FJ, Medina-Gallardo JF, Pérez-Navarro P, et al. Comparison of the Asthma Control Test (ACT) with lung function, levels of exhaled nitric oxide and control according to the Global Initiative for Asthma (GINA). Arch Bronconeumol 2010;46:370-7
  • Khalili B, Boggs PB, Shi R, et al. Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide. Ann Allergy Asthma Immunol 2008;101:124-9
  • Barbaro MP, Lacedonia D, Palladino GP, et al. Dyspnea perception in asthma: the role of airways inflammation, age and emotional status. Respir Med 2011;105:195-203
  • Bai TR, Cooper J, Koelmeyer T, et al. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med 2000;162:663-9
  • Phua GC, Macintyre NR. Inhaled corticosteroids in obstructive airway disease. Respir Care 2007;52:852-8
  • Melosini L, Dente FL, Bacci E, et al. Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control. J Asthma 2012;49:317-23
  • Ehrs PO, Larsson K. Treatment improves quality of life in patients with poor perception of asthma. Prim Care Respir J 2004;13:42-7
  • Ponte EV, Petroni J, Ramos DC, et al. Perception of asthma control in asthma patients. J Bras Pneumol 2007;33:635-40
  • Frisoni GB, Fedi V, Geroldi C, et al. Cognition and the perception of physical symptoms in the community-dwelling elderly. Behav Med 1999;25:5-12
  • Von Leupoldt A, Dahme B. The impact of emotions on symptom perception in patients with asthma and healthy controls. Psychophysiology 2013;50:1-4
  • Partridge MR, van der Molen T, Myrseth SE, et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006;6:13
  • Terzano C, Cremonesi G, Girbino G, et al. 1-year prospective real life monitoring of asthma control and quality of life in Italy. Respir Res 2012;13:112
  • Cazzoletti L, Marcon A, Janson C, et al. Therapy and health economics group of the European community respiratory health survey. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007;120:1360-7
  • Latry P, Pinet M, Labat A, et al. Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clin Ther 2008;30:1058-68
  • Melani AS, Bonavia M, Cilenti V, et al; Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105:930-8
  • Melani AS, Zanchetta D, Barbato N, et al; Associazione Italiana Pneumologi Ospedalieri Educational Group. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol 2004;93:439-46
  • Melani AS, Canessa P, Coloretti I, et al; Educational Study Group of the Italian Association of Hospital Pulmonologists (AIPO). Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use. Respir Med 2012;106:668-76
  • Saber H, Ghanei M. Extra-esophageal manifestations of gastroesophageal reflux disease: controversies between epidemiology and clinic. Open Respir Med J 2012;6:121-6
  • Zheng X, Guan W, Zheng J, et al. Smoking influences response to inhaled corticosteroids in patients with asthma: a meta-analysis. Curr Med Res Opin 2012;28:1791-8
  • Youkou A, Hasegawa T, Suzuki K, et al. Influence of obesity on control in asthmatic Japanese patients defined by the Japanese definition of obesity. Intern Med 2011;50:1911-16
  • Braido F, Baiardini I, Lagasio C, et al. Allergic rhinitis in asthma. Panminerva Med 2011;53:97-107
  • da Silva PL, de Mello MT, Cheik NC, et al. Interdisciplinary therapy improves biomarkers profile and lung function in asthmatic obese adolescents. Pediatr Pulmonol 2012;47:8-17
  • The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-63
  • Haahtela T. Lung function decline in asthma and early intervention with inhaled corticosteroids. Chest 2006;129:1405-6
  • Agache I, Akddis C, Jutel M, et al. Untangling asthma phenotypes and endotypes. Allergy 2012;67:835-46
  • Tubby C, Harrison T, Todd I, et al. Immunological basis of reversible and fixed airways disease. Clin Sci 2011;121:285-96
  • Woodruff PG, Modrek B, Choy DF, et al. T-helper Type 2–driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009;180:388-95
  • Wenzel S. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18:716-25
  • Cosmi L, Liotta F, Maggi E, et al. Th17 cells: new players in asthma pathogenesis. Allergy 2011;66:989-98
  • Olivieri D, Chetta A, Del Donno M, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997;155:1864-71
  • Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22
  • Hoshino M, Takahashi M, Takai Y, et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999;104:356-63
  • Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002;57:309-16
  • Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999;159(4 Pt 1):1043-51
  • Jeffery PK. Pathology of asthma. Br Med Bull 1992;48:23-39
  • Boulet LP, Turcotte H, Laviolette M, et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:1308-13
  • Sposato B, Pammolli A, Bove L, et al. A regular or an intermittent treatment for asthma: the long-term effect. Eur Rev Med Pharmacol Sci 2010;14:1037-44
  • Yamauchi K, Inoue H. Airway remodeling in asthma and irreversible airflow limitation – ECM deposition in airway and possible therapy for remodeling. Allergol Int 2007;56:321-9
  • Haahtela T, Tamminen K, Kava T, et al. Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma. J Allergy Clin immunol 2009;124:1180:5
  • Masoli M, Holt S, Weatherall M, et al. The dose–response relationship of inhaled corticosteroids in asthma. Curr Allergy Asthma Rep 2004;4:144-8
  • O’Byrne PM, Nava IP, Kallen A, et al. Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled β2-agonists in achieving asthma control. Chest 2008;134:1192-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.